Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial

Gelijkaardige items

• A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
  door: Han, Changsu, et al.
  Gepubliceerd in: (2018)
• An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features
  door: Pae, Chi-Un, et al.
  Gepubliceerd in: (2008)
• Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway
  door: Cocchi, Enrico, et al.
  Gepubliceerd in: (2016)
• The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study
  door: Han, Changsu, et al.
  Gepubliceerd in: (2019)
• Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
  door: Wang, Sheng-Min, et al.
  Gepubliceerd in: (2018)